Founder, Chair and CEO
Founder, Chair, and CEO of Lysogene, Ms. Karen Pignet-Aiach is also the mother of a child with MPS IIIA.
Stéphane Durant des Aulnois
Chief Financial Officer
Stéphane Durant des Aulnois joined Lysogene in October 2019 as Chief Financial Officer, also supervising the Alliance Management and Business Development departments.
Head of Non-Clinical Development
Dr. Michaël Hocquemiller is in charge of the non-clinical development of Lysogene’s gene therapy products including…